8V6.F SCANDINAV.CHEMOTECH CL.B

Healthcare Biotechnology Frankfurt Exchange
0.1498 EUR
Close of Nov 11, 2026
0.0840 0.4400
Market cap
EUR 3.57M
P/E
-
P/B
310.07x
ROE
-5,499.7%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 8V6.F undervalued?

Graham number

The Graham number of SCANDINAV.CHEMOTECH CL.B cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

SCANDINAV.CHEMOTECH CL.B fundamental analysis

No fundamental analysis for SCANDINAV.CHEMOTECH CL.B yet.

SCANDINAV.CHEMOTECH CL.B stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About SCANDINAV.CHEMOTECH CL.B

Neem's Hill AB, a medical technology company, engages in the development of patented treatment alternatives for humans and animals with cancer in Sweden and internationally. It offers IQwave, an electroporation that generates tumor-specific electrical stimulation for the treatment of solid superficial tumors of various sizes and locations. Neem's Hill AB was formerly known as Scandinavian ChemoTech AB (publ) and changed its name to Neem's Hill AB in July 2026. The company wa…

Full company profile